In this roundtable discussion, Dr. John Lasala of Washington University in St. Louis interviews Dr. Bill O’Neill (Henry Ford Hospital, Detroit, MI), Dr. Bill Lombardi (University of Washington, Seattle, WA), and Dr. Jeff Moses (Columbia University, New York, NY) on the current data regarding high-risk patients undergoing Protected PCI. During this interview, Dr. Moses provides … Continue reading “Protected PCI: Current Data and Best Practices in High-Risk Patients”
Dr. Jeffrey Moses, Director of Interventional Cardiac Therapeutics at Columbia University Medical Center, NY and Director of Complex Coronary Interventions at St. Francis Hospital, presents modern day SVG PCI techniques and data to optimize SVG intervention success. Tweet this, subscribe or find an Impella® training course near you.
Drs. John Lasala, Bill O’Neill, Jeff Moses, and Bill Lombardi explain the benefit of Impella support during Protected PCI for revascularization.
Impella 2.5 and Impella CP are now approved by the FDA as safe and effective for use during high-risk PCI procedures. Learn more about the data and the clinical guidelines that support the approval. Additionally, learn how to identify patients who can benefit from Protected PCI and revascularization. Tune into this valuable conversation! Chapters include:
Maintaining Hemodynamic stability during high-risk PCI
Complete Revascularization is the Therapeutic Goal
Nearly 100 interventional and clinical cardiologists from around the country gathered in Fort Lauderdale to collaborate and watch presentations and case reviews from leading physicians in the industry. The course, “CHIP: Hemodynamic Support and Complex PCI” taking place on January 23-24, 2016, was hosted by the Cardiovascular Research Foundation and was organized by leading interventional cardiologists in the field: Drs. Ajay Kirtane, Marty Leon, and Jeffrey Moses from New York Presbyterian Hospital/Columbia University Medical Center, and Dr. John Lasala from Washington University School of Medicine.[caption id="attachment_519" align="alignright" width="225"] Breakout workshops included lessons with the hemodynamic simulator, large bore closure training/simulator, chronic total occlusion (CTO) simulation, and adjunctive devices.[/caption]Continue readingDr. Jeff Moses Illustrates Typical High-Risk Patient at CHIP Course
The Protected PCI blogging team recorded our latest podcast at the Abiomed Advanced Users course in Europe, where Dr. Jeffrey Moses discussed Protected PCI and which patients to treat. An internationally recognized interventional cardiologist, Dr. Moses highlighted three areas of concern in his discussion; We don't diagnose, we don't treat, and we don't treat adequately. Continue readingDr. Jeffrey Moses Discusses Three Key Areas of Patient Concerns
There is a growing need in the cath lab to treat more high risk patients, per the CHIP initiative. Dr. Ajay Kirtane, Dr. John Lasala, Dr. Jeff Popma and Dr. Jeff Moses discuss. Subscribe or join the conversation by following us on Twitter: @ProtectedPCI IMP-820-16